SecBot SecBot
Insider Cluster (3 insiders) ·Filed Aug 24, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 3 insiders, $0.2M total
Actionable Insight • Neutral

This insider cluster is too small to warrant a directional trade. Monitor for any upcoming earnings or pipeline catalysts (e.g., ZORYVE label expansion) that could drive the stock, but ignore this selling as noise.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$24.86
T+0 close · Aug 24, 2026 · via day close
Latest settled
+6.11%
T+20 · $26.38 · next T+60 tomorrow
Vs SPY
+5.87%
α at T+20
Latest observation
+26.84%
T+56 · FF3 residual α
  1. T+0 · Aug 25 $24.86entry
  2. T+1 · 3mo ago +1.13%α +1.10% · $25.14
  3. T+5 · 3mo ago −4.46%α −3.93% · $23.75
  4. T+20 · 8w ago +6.11%α +5.87% · $26.38
  5. T+58 · todayOpen
  6. T+60 · tomorrow Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three insiders at Arcutis Biotherapeutics sold a total of $198K in open-market sales over a 7-day window, with the largest sale ($124K) by Director Howard Welgus. The total value is only ~0.006% of the company's $3.2B market cap, making this a trivial cluster by proportionality. No cross-filing context suggests distress or material negative news; the cluster is neutral and low-impact.

Key Financial Metrics

Direction
selling
Total Value
$198.0K
Insiders
3

Key Facts

  • Three insiders sold shares totaling $198K in open-market sales from Aug 13-20, 2026.
  • Total sales represent only ~0.006% of Arcutis's $3.2B market cap, well below the 0.1% materiality threshold.
  • Director Howard Welgus accounted for the largest sale at $124K; Director Terrie Curran also exercised non-cash derivatives.
  • No cross-filing context indicates distress, earnings miss, or material negative news.

Financial Impact

Total insider sales of $198K, or ~0.006% of market cap, immaterial.

insider ownership

Risk Factors

  • Insider sales could accelerate if insiders perceive the stock as fully valued near $26-27.
  • No material risk from this cluster; the primary risk is the company's execution on its commercial-stage dermatology pipeline.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARQT-1787615130398

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (11h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 24, 2026